Joinn Laboratories(China)Co.,Ltd. (SHA:603127)
China · Delayed Price · Currency is CNY 39.20
-0.93 (-2.32%)
May 12, 2026, 3:00 PM CST
SHA:603127 Cash Flow Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Net Income | 495.08 | 297.84 | 74.08 | 396.99 | 1,074 | 557.46 |
Depreciation & Amortization | 136.42 | 136.42 | 130.32 | 129.51 | 122.21 | 96.44 |
Other Amortization | 37.65 | 37.65 | 17.89 | 15.6 | 7.51 | 5.76 |
Loss (Gain) From Sale of Assets | -0.41 | -0.41 | 0.05 | 0.07 | 0.41 | 0.35 |
Asset Writedown & Restructuring Costs | -429.34 | -429.34 | 123.1 | 288.99 | -333.07 | -125.26 |
Loss (Gain) From Sale of Investments | 49.22 | 49.22 | -28.9 | -51.49 | -32.21 | -49.45 |
Loss (Gain) on Equity Investments | - | - | - | - | 2.69 | - |
Stock-Based Compensation | - | - | - | 6.03 | 9.59 | 23.51 |
Provision & Write-off of Bad Debts | -4.89 | -4.89 | 18.92 | 9.99 | 5.8 | 0.83 |
Other Operating Activities | -126.68 | 8.1 | 3.13 | -39.79 | -45.5 | 36.59 |
Change in Accounts Receivable | 62.3 | 62.3 | -5.15 | -91.41 | -131.88 | -64.83 |
Change in Inventory | 214.52 | 214.52 | 384.2 | 239.36 | -241.99 | -226.74 |
Change in Accounts Payable | 68.23 | 68.23 | -331.89 | -252.97 | 71.73 | 444.28 |
Change in Unearned Revenue | 4.82 | 4.82 | -6.57 | -6.19 | -25.94 | -19.32 |
Change in Other Net Operating Assets | - | - | - | - | 461.81 | - |
Operating Cash Flow | 507.03 | 444.57 | 338.93 | 622.88 | 945.43 | 685.66 |
Operating Cash Flow Growth | 78.45% | 31.17% | -45.59% | -34.12% | 37.89% | 60.06% |
Capital Expenditures | -466.07 | -143.6 | -269.39 | -192.72 | -268.75 | -237.24 |
Sale of Property, Plant & Equipment | 1.37 | 1.36 | 0.57 | 0.15 | 0.11 | 0.25 |
Cash Acquisitions | - | - | - | -90.06 | -2,286 | - |
Divestitures | - | - | - | - | 849.71 | - |
Sale (Purchase) of Intangibles | - | - | - | - | -6.09 | - |
Investment in Securities | 227.94 | -369.88 | -1,898 | -65.85 | -436.01 | -1,853 |
Other Investing Activities | 109.34 | 92.93 | 204.05 | 33.06 | 12.09 | 20.31 |
Investing Cash Flow | -127.42 | -419.19 | -1,963 | -315.43 | -2,134 | -2,070 |
Long-Term Debt Issued | - | - | - | - | 55.45 | - |
Total Debt Issued | - | - | - | - | 55.45 | - |
Long-Term Debt Repaid | - | -34.59 | -28.74 | -33.77 | -82.8 | -26.13 |
Total Debt Repaid | -34.59 | -34.59 | -28.74 | -33.77 | -82.8 | -26.13 |
Net Debt Issued (Repaid) | -34.59 | -34.59 | -28.74 | -33.77 | -27.35 | -26.13 |
Issuance of Common Stock | - | - | - | - | 60.52 | 5,422 |
Repurchase of Common Stock | -10.01 | -10.01 | -107.86 | -113.58 | -22.5 | -0.65 |
Common Dividends Paid | -22.39 | -22.39 | -119.63 | -214.33 | -137.36 | -95.27 |
Other Financing Activities | 13.22 | - | -9.39 | - | 27.37 | -9.1 |
Financing Cash Flow | -53.77 | -66.98 | -265.63 | -361.68 | -99.33 | 5,290 |
Foreign Exchange Rate Adjustments | -19.33 | -11.74 | 1.28 | 8.41 | 37.47 | -60.9 |
Net Cash Flow | 306.51 | -53.35 | -1,888 | -45.82 | -1,251 | 3,845 |
Free Cash Flow | 40.96 | 300.96 | 69.54 | 430.15 | 676.68 | 448.41 |
Free Cash Flow Growth | 52.06% | 332.81% | -83.83% | -36.43% | 50.91% | 60.49% |
Free Cash Flow Margin | 2.43% | 18.16% | 3.45% | 18.10% | 29.84% | 29.57% |
Free Cash Flow Per Share | 0.06 | 0.40 | 0.09 | 0.57 | 0.90 | 0.61 |
Cash Interest Paid | - | - | - | - | 2.1 | - |
Cash Income Tax Paid | 52.03 | 55.86 | 114.09 | 177.54 | 123.55 | 75.44 |
Levered Free Cash Flow | -831.81 | 117.74 | -26.89 | 181.72 | -683.05 | 232.88 |
Unlevered Free Cash Flow | -830.92 | 118.63 | -25.36 | 183.69 | -680.81 | 235.35 |
Change in Working Capital | 349.98 | 349.98 | 0.35 | -133.02 | 133.74 | 139.44 |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.